Activation of protein kinase C subtypes α, γ, δ, ϵ, ζ, and η by tumor-promoting and nontumor-promoting agents
- 21 March 1997
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 53 (6), 865-875
- https://doi.org/10.1016/s0006-2952(96)00885-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Protein kinase C isoenzymes: divergence in signal transduction?Biochemical Journal, 1993
- Effect of tumour-promoting phorbol ester, thrombin and vasopressin on translocation of three distinct protein kinase C isoforms in human platelets and regulation by calciumBiochemical Journal, 1992
- Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase CScience, 1992
- Possible regulatory functions of protein kinase C-α and -ε isoenzymes in rat renal mesangial cells. Stimulation of prostaglandin synthesis and feedback inhibition of angiotensin II-stimulated phosphoinositide hydrolysisBiochemical Journal, 1991
- Protein kinase CPharmacology & Therapeutics, 1991
- Both tumour-promoting and non-promoting phorbol esters inhibit [125I]EGF binding and stimulate the phosphorylation of an 80 kd protein kinase C substrate protein in intact quiescent Swiss 3T3 cellsCarcinogenesis: Integrative Cancer Research, 1990
- Structure/activity analysis of resiniferatoxin analogsPhytotherapy Research, 1989
- Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitroCarcinogenesis: Integrative Cancer Research, 1988
- Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptorBiochemical and Biophysical Research Communications, 1985
- Investigations into the skin-irritant properties of resiniferonol ortho estersInflammation, 1979